IBDEI0F5 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20299,0)
 ;;=054.9^^129^1206^9
 ;;^UTILITY(U,$J,358.3,20299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20299,1,3,0)
 ;;=3^054.9
 ;;^UTILITY(U,$J,358.3,20299,1,4,0)
 ;;=4^HERPES SIMPLEX
 ;;^UTILITY(U,$J,358.3,20299,2)
 ;;=^56902
 ;;^UTILITY(U,$J,358.3,20300,0)
 ;;=780.60^^129^1206^7
 ;;^UTILITY(U,$J,358.3,20300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20300,1,3,0)
 ;;=3^780.60
 ;;^UTILITY(U,$J,358.3,20300,1,4,0)
 ;;=4^FEVER NOS
 ;;^UTILITY(U,$J,358.3,20300,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,20301,0)
 ;;=780.62^^129^1206^13
 ;;^UTILITY(U,$J,358.3,20301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20301,1,3,0)
 ;;=3^780.62
 ;;^UTILITY(U,$J,358.3,20301,1,4,0)
 ;;=4^POST-PROCEDURAL FEVER
 ;;^UTILITY(U,$J,358.3,20301,2)
 ;;=^336668
 ;;^UTILITY(U,$J,358.3,20302,0)
 ;;=780.63^^129^1206^14
 ;;^UTILITY(U,$J,358.3,20302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20302,1,3,0)
 ;;=3^780.63
 ;;^UTILITY(U,$J,358.3,20302,1,4,0)
 ;;=4^POST-VACCINATION FEVER
 ;;^UTILITY(U,$J,358.3,20302,2)
 ;;=^336669
 ;;^UTILITY(U,$J,358.3,20303,0)
 ;;=780.64^^129^1206^3
 ;;^UTILITY(U,$J,358.3,20303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20303,1,3,0)
 ;;=3^780.64
 ;;^UTILITY(U,$J,358.3,20303,1,4,0)
 ;;=4^CHILLS-W/O FEVER
 ;;^UTILITY(U,$J,358.3,20303,2)
 ;;=^336670
 ;;^UTILITY(U,$J,358.3,20304,0)
 ;;=413.9^^129^1207^1
 ;;^UTILITY(U,$J,358.3,20304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20304,1,3,0)
 ;;=3^413.9
 ;;^UTILITY(U,$J,358.3,20304,1,4,0)
 ;;=4^ANGINA PECTORIS/STABLE
 ;;^UTILITY(U,$J,358.3,20304,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,20305,0)
 ;;=427.31^^129^1207^5
 ;;^UTILITY(U,$J,358.3,20305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20305,1,3,0)
 ;;=3^427.31
 ;;^UTILITY(U,$J,358.3,20305,1,4,0)
 ;;=4^ATRIAL FIBRILLATION
 ;;^UTILITY(U,$J,358.3,20305,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,20306,0)
 ;;=427.9^^129^1207^7
 ;;^UTILITY(U,$J,358.3,20306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20306,1,3,0)
 ;;=3^427.9
 ;;^UTILITY(U,$J,358.3,20306,1,4,0)
 ;;=4^CARDIAC DYSRHYTHMIA
 ;;^UTILITY(U,$J,358.3,20306,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,20307,0)
 ;;=428.0^^129^1207^8
 ;;^UTILITY(U,$J,358.3,20307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20307,1,3,0)
 ;;=3^428.0
 ;;^UTILITY(U,$J,358.3,20307,1,4,0)
 ;;=4^CHF
 ;;^UTILITY(U,$J,358.3,20307,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,20308,0)
 ;;=414.9^^129^1207^10
 ;;^UTILITY(U,$J,358.3,20308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20308,1,3,0)
 ;;=3^414.9
 ;;^UTILITY(U,$J,358.3,20308,1,4,0)
 ;;=4^ISCHEMIC HEART DIS, CHRONIC
 ;;^UTILITY(U,$J,358.3,20308,2)
 ;;=^24401
 ;;^UTILITY(U,$J,358.3,20309,0)
 ;;=394.9^^129^1207^12
 ;;^UTILITY(U,$J,358.3,20309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20309,1,3,0)
 ;;=3^394.9
 ;;^UTILITY(U,$J,358.3,20309,1,4,0)
 ;;=4^MITRAL VALVE DISEASE
 ;;^UTILITY(U,$J,358.3,20309,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,20310,0)
 ;;=443.9^^129^1207^13
 ;;^UTILITY(U,$J,358.3,20310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20310,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,20310,1,4,0)
 ;;=4^PERIPH VASCULAR DIS
 ;;^UTILITY(U,$J,358.3,20310,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,20311,0)
 ;;=424.1^^129^1207^3
 ;;^UTILITY(U,$J,358.3,20311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20311,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,20311,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,20311,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,20312,0)
 ;;=459.81^^129^1207^14
 ;;^UTILITY(U,$J,358.3,20312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20312,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,20312,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,20312,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,20313,0)
 ;;=411.1^^129^1207^2
 ;;^UTILITY(U,$J,358.3,20313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20313,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,20313,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,20313,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,20314,0)
 ;;=429.2^^129^1207^4
 ;;^UTILITY(U,$J,358.3,20314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20314,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,20314,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,20314,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,20315,0)
 ;;=414.01^^129^1207^6
 ;;^UTILITY(U,$J,358.3,20315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20315,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,20315,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,20315,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,20316,0)
 ;;=401.9^^129^1207^9
 ;;^UTILITY(U,$J,358.3,20316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20316,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,20316,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,20316,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,20317,0)
 ;;=394.0^^129^1207^11
 ;;^UTILITY(U,$J,358.3,20317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20317,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,20317,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,20317,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,20318,0)
 ;;=285.9^^129^1208^1
 ;;^UTILITY(U,$J,358.3,20318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20318,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,20318,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,20318,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,20319,0)
 ;;=266.2^^129^1208^2
 ;;^UTILITY(U,$J,358.3,20319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20319,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,20319,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,20319,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,20320,0)
 ;;=272.0^^129^1208^3
 ;;^UTILITY(U,$J,358.3,20320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20320,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,20320,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,20320,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,20321,0)
 ;;=250.00^^129^1208^6
 ;;^UTILITY(U,$J,358.3,20321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20321,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,20321,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
 ;;^UTILITY(U,$J,358.3,20321,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,20322,0)
 ;;=250.02^^129^1208^5
 ;;^UTILITY(U,$J,358.3,20322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20322,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,20322,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE II UNCONT
 ;;^UTILITY(U,$J,358.3,20322,2)
 ;;=^295704
 ;;^UTILITY(U,$J,358.3,20323,0)
 ;;=272.4^^129^1208^9
 ;;^UTILITY(U,$J,358.3,20323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20323,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,20323,1,4,0)
 ;;=4^HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,20323,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,20324,0)
 ;;=244.9^^129^1208^10
 ;;^UTILITY(U,$J,358.3,20324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20324,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,20324,1,4,0)
 ;;=4^HYPOTHYROIDISM
 ;;^UTILITY(U,$J,358.3,20324,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,20325,0)
 ;;=250.01^^129^1208^4
 ;;^UTILITY(U,$J,358.3,20325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20325,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,20325,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE I
 ;;^UTILITY(U,$J,358.3,20325,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,20326,0)
 ;;=278.01^^129^1208^11
 ;;^UTILITY(U,$J,358.3,20326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20326,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,20326,1,4,0)
 ;;=4^OBESITY, MORBID
 ;;^UTILITY(U,$J,358.3,20326,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,20327,0)
 ;;=286.59^^129^1208^7
 ;;^UTILITY(U,$J,358.3,20327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20327,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,20327,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,20327,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,20328,0)
 ;;=268.9^^129^1208^12
 ;;^UTILITY(U,$J,358.3,20328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20328,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,20328,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,20328,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,20329,0)
 ;;=790.29^^129^1208^8
 ;;^UTILITY(U,$J,358.3,20329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20329,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,20329,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,20329,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,20330,0)
 ;;=389.9^^129^1209^7
 ;;^UTILITY(U,$J,358.3,20330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20330,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,20330,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,20330,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,20331,0)
 ;;=380.4^^129^1209^8
 ;;^UTILITY(U,$J,358.3,20331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20331,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,20331,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,20331,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,20332,0)
 ;;=382.9^^129^1209^9
 ;;^UTILITY(U,$J,358.3,20332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20332,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,20332,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,20332,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,20333,0)
 ;;=365.11^^129^1209^5
 ;;^UTILITY(U,$J,358.3,20333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20333,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,20333,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,20333,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,20334,0)
 ;;=372.72^^129^1209^10
 ;;^UTILITY(U,$J,358.3,20334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20334,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,20334,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,20334,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,20335,0)
 ;;=365.70^^129^1209^1
 ;;^UTILITY(U,$J,358.3,20335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20335,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,20335,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,20335,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,20336,0)
 ;;=365.71^^129^1209^3
 ;;^UTILITY(U,$J,358.3,20336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20336,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,20336,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
